×
About 83 results

ALLMedicine™ Aceruloplasminemia Center

Research & Reviews  32 results

Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients
https://clinicaltrials.gov/ct2/show/NCT04184453

Nov 23rd, 2021 - Diabetes is one of the most severe symptom in aceruloplasminemia. In this study, we use R2* of pancreas MRI to evaluate the effect of deferiprone treatment.

Asymptomatic ocular manifestations of aceruloplasminemia in two adult Caucasian sibling...
https://doi.org/10.1097/ICB.0000000000001166
Retinal Cases & Brief Reports; Furashova O, Mielke S et. al.

May 21st, 2021 - To report ocular manifestations of aceruloplasminemia (aCP) in two adult Caucasian siblings.Methods: The ocular findings were investigated using multimodal imaging approach including color fundus photography, fluorescein angiography, autofluoresce...

Quantification of different iron forms in the aceruloplasminemia brain to explore iron-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055714
NeuroImage. Clinical; Vroegindeweij LHP, Bossoni L et. al.

Apr 12th, 2021 - Aceruloplasminemia is an ultra-rare neurodegenerative disorder associated with massive brain iron deposits, of which the molecular composition is unknown. We aimed to quantitatively determine the molecular iron forms in the aceruloplasminemia brai...

Aceruloplasminemia
https://rarediseases.info.nih.gov/diseases/9499/aceruloplasminemia

Mar 4th, 2021 - Aceruloplasminemia causes a build-up of iron in the brain and the organs of the body. Signs and symptoms begin in adulthood. People with aceruloplasminemia develop anemia, diabetes, and eye problems. Over time, difficulty controlling movements may...

see more →

Clinicaltrials.gov  1 results

Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients
https://clinicaltrials.gov/ct2/show/NCT04184453

Nov 23rd, 2021 - Diabetes is one of the most severe symptom in aceruloplasminemia. In this study, we use R2* of pancreas MRI to evaluate the effect of deferiprone treatment.

see more →